Brief: BD Receives FDA Emergency Use Authorization For Covid-19, Influenza A/B, Rsv Combination Test
08/02/2023 11:59
Feb 8 (Reuters) - Becton Dickinson and Co BDX.N :
* BD RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19,
INFLUENZA A/B, RSV COMBINATION TEST
Source text for Eikon: ID:nPnbY32yfa
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)